ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2034

Increased Invasive Capacity and Metabolic Activity in Synovial Fibroblasts from Children with Downs Arthropathy Compared to Juvenile Idiopathic Arthritis

Sharon Ansboro1, Charlene Foley2, Monika Biniecka3, Emma MacDermott4, Douglas J. Veale5, Ronan Mullan6, Orla G Killeen7 and Ursula Fearon8, 1Molecular Rheumatology, Trinty College Dublin, Dublin, Ireland, 2Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland, 3Department of Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 4Our Lady's Children's Hospital, Crumlin, Dublin, Ireland, 5Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 6Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, 7National Centre for Paediatric Rheumatology, Dublin, Ireland, 8Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Metabolism, Pediatric rheumatology, synovial cells, synovial fluid and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Downs Arthropathy (DA) is an inflammatory joint condition affecting children with Down syndrome, which is under-recognised, has a delayed diagnoses, resulting in chronic disability. Our clinical research showed an increased risk of arthritis in children with Down syndrome, with the prevalence in Ireland for DA 18-21 times greater than Juvenile idiopathic Arthritis (JIA). Furthermore children with DA had more erosive joint damage compared to JIA. This observed increase in erosive disease suggests that DA synovial fibroblasts (SFC) which reside in the hyperplastic lining layer of the synovium may have a more invasive phenotype, however to date little is known about the underlying mechanisms that drive disease pathogenesis in DA.

The aim of the present study is to compare the function of primary synovial fibroblasts from children with DA vs JIA.

Methods:

Synovial tissue biopsies were obtained from children with DA and JIA using ultrasound guided biopsies and assessed histologically for levels of vascularity, lining layer hyperplasia and sub-lining inflammation. Primary synovial fibroblasts were isolated from both DA and JIA and functional comparisons performed at passage 3. DASFC and JIASFC migration was assessed by wound repair scratch assays. Biocoat Matrigel™ Invasion Chambers were used to assess DASFC and JIASFC invasiveness. DASFC and JIASFC bioenergetic activity was assessed using the XFe96-Flux-analyser, where oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), reflecting oxidative phosphorylation and glycolysis respectively were quantified. Further metabolic outputs were assessed following the mitochondrial stress test where cells were treated with oligomycin, FCCP and antimycin A. Finally, glycolytic gene expression was assessed by Real-time PCR.

Results:

Synovial tissue analysis demonstrated a marked increase in synovial lining layer hyperplasia in DA vs JIA, with a median lining layer thickness score of 6(3-9) in DA vs 3(2-4) JIA, suggesting a more invasive pannus in DA compared to JIA. An increase in the migration of DASFC compared to JIASFC was observed, an effect paralled by a significant increase in the invasive capacity of DASFC vs JIASFC. These effects were potentiated in response to TNFa stimulation. Metabolic activity was markedly different in DASFC vs JIASFC, with DASFC displaying increased basal metabolic activity compared to JIASFC. Moreover, following the mitochondrial stress test, a substantial increase in mitochondrial spare reserve capacity was observed in DASFC when compared to JIASFC, suggesting that DASFC have an enhanced ability to respond to sudden changes in the energy demands of the cell. Finally, an increase in metabolic genes HK2 and PDK2 were observed in DASFC vs JIASFC.

Conclusion:

This is the first study to demonstrate differences in synovial pathology of children with DA vs JIA, demonstrating a marked increase in the invasive layer of DA synovium compared to JIA. This was paralleled by a significant increase in the migratory, invasive and bioenergetic profile of DASFC vs JIASFC, a phenotype that may contribute to the increased erosive disease observed in DA compared to JIA.


Disclosure: S. Ansboro, None; C. Foley, None; M. Biniecka, None; E. MacDermott, None; D. J. Veale, None; R. Mullan, None; O. G. Killeen, None; U. Fearon, Pfizer, Inc., 2.

To cite this abstract in AMA style:

Ansboro S, Foley C, Biniecka M, MacDermott E, Veale DJ, Mullan R, Killeen OG, Fearon U. Increased Invasive Capacity and Metabolic Activity in Synovial Fibroblasts from Children with Downs Arthropathy Compared to Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-invasive-capacity-and-metabolic-activity-in-synovial-fibroblasts-from-children-with-downs-arthropathy-compared-to-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-invasive-capacity-and-metabolic-activity-in-synovial-fibroblasts-from-children-with-downs-arthropathy-compared-to-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology